 |
|
| New therapies, including medications, medical devices and surgical procedures, are evaluated in research studies known as clinical trials. Often these new therapies are investigational, which means they are not yet approved by the U.S. Food and Drug Administration for general use. However participation in clinical trials offers the potential for new treatment options and allows patients to participate with researchers in driving the discovery of effective therapies for epilepsy. There are always risks involved, some known and possibly some that are unknowns, and patients should consult with their physicians in considering the appropriateness of a clinical trial for their particular situation. Clinical trials are done under the supervision of the FDA. |
|
We are currently participating in many clinical trials for a vast amount of therapies for different illnesses. Some examples are for the treatment of:
We are currently performing many trials seeking a wide spectrum of patients with an established history of partial or complex epilepsy. The patient should be between the ages of 12 and 80, who are having break-through seizure activity while on a stable dose of at least one but no more than 3 AEDs, do not have a history of Status Epilepticus within the last 6 months, and are able and willing to provide consent.
If qualified, you will receive an FDA approved medication for epilepsy, an extensive evaluation, and study related assessments for this drug's effectiveness on Epilepsy at NO COST to you. Compensation for travel is available.
Diabetic Peripheral Neuropathy We are currently performing trials seeking patients with an established history of type 1 or type 2 diabetes and experience hand, foot, or leg pain caused by diabetes-related nerve damage. The patient should have signs or symptoms for at least 6months, be at least 18 years of age at time of enrollment, and are able and willing to provide consent.
If qualified, you will receive an FDA approved medication for diabetic peripheral neuropathy, an extensive neuropathy evaluation, and study related assessments for this drug's effectiveness on Diabetic Peripheral Neuropathy at NO COST to you. Compensation for travel is available.
Pain Management - Low Back Pain We are currently seeking patients with an established history of chronic low back pain, who are currently dissatisfied with their current opioid or opioid-like therapy. The patients should be between the ages of 18 and 80, and who are able and willing to provide consent. If qualified, you will receive an FDA approved medication for low back pain, an extensive low back pain evaluation, and study related assessments for this drug's effectiveness on low back pain at NO COST to you. Compensation for travel is available. If you are interested in this study:
Alzheimer's Disease:
We are currently conducting clinical research trials for patients with a diagnosis of probable Alzheimer’s disease. Patient should be between the ages of 50 to 89 of either gender. The patient should be of able to understand, read, and write English.
If qualified, you will receive an FDA approved medication for Alzheimer's Disease, an extensive dementia evaluation, and study related assessments for this drug's effectiveness on Alzheimer's Disease at NO COST to you. Compensation for travel is available.
|
|||||||||||||||||
| home - about us - our team - our studies - faqs - contact us |